###begin article-title 0
###xml 119 126 119 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNFSF4 </italic>
Identification of possible candidate genes regulating Sjogren's syndrome-associated autoimmunity: a potential role for TNFSF4 in autoimmune exocrinopathy
###end article-title 0
###begin p 1
This is an open access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Introduction
###end title 2
###begin p 3
###xml 356 360 356 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec2</italic>
###xml 435 439 435 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec1</italic>
###xml 478 482 <span type="species:ncbi:10090">mice</span>
###xml 587 591 <span type="species:ncbi:10090">mice</span>
Sjogren syndrome (SjS) is a systemic autoimmune disease in which an immunological attack primarily against the salivary and lacrimal glands results in the loss of acinar cell tissue and function, leading to stomatitis sicca and keratoconjunctivitis sicca. In recent years, two genetic regions, one on chromosome 1 (designated autoimmune exocrinopathy 2 or Aec2) and the second on chromosome 3 (designated autoimmune exocrinopathy 1 or Aec1) derived from nonobese diabetic (NOD) mice, have been shown to be necessary and sufficient to replicate SjS-like disease in nonsusceptible C57BL/6 mice.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 84 92 84 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec1Aec2</italic>
###xml 175 180 175 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec2 </italic>
###xml 50 55 <span type="species:ncbi:10090">mouse</span>
Starting with the SjS-susceptible C57BL/6-derived mouse, referred to as C57BL/6.NOD-Aec1Aec2, we generated a large set of recombinant inbred (RI) lines containing portions of Aec2 as a means of identifying more precisely the genetic elements of chromosome 1 responsible for disease development.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 86 91 86 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec2 </italic>
###xml 521 532 519 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ox40 ligand</italic>
###xml 435 439 <span type="species:ncbi:10090">mice</span>
Disease profiling of these RI lines has revealed that the SjS susceptibility genes of Aec2 lie within a region located at approximately 79 +/- 5 cM distal to the centromere, as defined by microsatellite markers. This chromosomal region contains several sets of genes known to correlate with various immunopathological features of SjS as well as disease susceptibility genes for both type 1 diabetes and systemic lupus erythematosus in mice. One gene in particular, tumor necrosis factor (ligand) superfamily member 4 (or Ox40 ligand), encoding a product whose biological functions correlate with both physiological homeostasis and immune regulations, could be a potential candidate SjS susceptibility gene.
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
###xml 379 383 <span type="species:ncbi:10090">mice</span>
These new RI lines represent the first step not only in fine mapping SjS susceptibility loci but also in identifying potential candidate SjS susceptibility genes. Identification of possible candidate genes permits construction of models describing underlying molecular pathogenic mechanisms in this model of SjS and establishes a basis for construction of specific gene knockout mice.
###end p 9
###begin p 10
See related editorial by Andersson, 
###end p 10
###begin title 11
Introduction
###end title 11
###begin p 12
###xml 264 265 264 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 266 267 266 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 569 570 569 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 661 662 661 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 663 664 663 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 901 903 901 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 904 906 904 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 47 52 <span type="species:ncbi:9606">human</span>
###xml 491 496 <span type="species:ncbi:10090">mouse</span>
###xml 654 659 <span type="species:ncbi:10090">mouse</span>
###xml 832 836 <span type="species:ncbi:10090">mice</span>
Sjogren syndrome (SjS) is a chronic, systemic, human autoimmune disease in which an immunological attack initially against the salivary and lacrimal glands results, respectively, in dry mouth (stomatitis sicca) and dry eye (keratoconjunctivitis sicca) disease(s) [1-3]. Despite efforts to define the genetic, environmental, and immunological bases of SjS, the underlying etiology of this disease remains ill defined. In attempts to better define the nature of SjS autoimmunity, a variety of mouse models exhibiting various aspects of SjS have been studied extensively [4]. One of the more intensively studied models of SjS is the nonobese diabetic (NOD) mouse [5-9]. Based on disease profiling of various congenic partners and gene knockout lines of NOD, we have proposed that the development and onset of SjS-like disease in these mice can be divided into at least three distinct consecutive phases [10-19]. In phase 1, a number of aberrant physiological and biochemical activities, thought to result from a genetically based retarded salivary gland organogenesis and increased acinar cell apoptosis, occur prior to and independent of detectable autoimmunity. In phase 2, believed to result from the glandular cell injury of phase 1, small numbers of macrophages and dendritic cells are attracted to the exocrine gland where these sentinel cells recruit T and B lymphocytes that form lymphocytic foci (LF), some of which histologically appear as germinal centers. In phase 3, the onset of clinical disease as defined by salivary and lacrimal gland secretory dysfunction occurs, possibly resulting first from the production of autoantibodies that interfere with the neural-acinar cell signaling pathways and then from progressive loss of acinar cell mass hastened by the action of effector T cells.
###end p 12
###begin p 13
###xml 265 267 265 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 268 270 268 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 366 368 366 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H2</italic>
###xml 368 369 368 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 368 369 368 369 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>b</italic></sup>
###xml 392 395 392 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I-A</italic>
###xml 395 396 395 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 395 397 395 397 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>g</italic>7</sup>
###xml 397 402 397 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Idd1 </italic>
###xml 456 459 456 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I-A</italic>
###xml 459 461 459 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b </italic>
###xml 459 461 459 461 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>b </italic></sup>
###xml 468 470 468 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 578 582 578 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Idd </italic>
###xml 598 603 598 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Idd1 </italic>
###xml 617 621 617 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Idd9</italic>
###xml 623 628 623 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Idd10</italic>
###xml 634 639 634 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Idd13</italic>
###xml 675 680 675 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Idd3 </italic>
###xml 700 705 700 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Idd5 </italic>
###xml 798 800 798 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 843 848 843 848 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Idd3 </italic>
###xml 852 857 852 857 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Idd5 </italic>
###xml 1047 1049 1047 1049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1167 1172 1167 1172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Idd5 </italic>
###xml 1224 1228 1224 1228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec2</italic>
###xml 1351 1356 1351 1356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Idd3 </italic>
###xml 1372 1376 1372 1376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec1</italic>
###xml 1446 1454 1446 1454 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec1Aec2</italic>
###xml 1596 1598 1596 1598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 78 82 <span type="species:ncbi:10090">mice</span>
###xml 139 143 <span type="species:ncbi:10090">mice</span>
###xml 295 301 <span type="species:ncbi:9606">humans</span>
###xml 792 796 <span type="species:ncbi:10090">mice</span>
###xml 874 878 <span type="species:ncbi:10090">mice</span>
###xml 911 915 <span type="species:ncbi:10090">mice</span>
###xml 1403 1408 <span type="species:ncbi:10090">mouse</span>
A genetic predisposition for development and onset of SjS-like disease in NOD mice has also been defined. First, SjS-like disease in these mice appears independent of or only weakly associated with major histocompatibility complex (MHC) class I and class II genes [10,20], thus mimicking SjS in humans. This can be seen by the fact that the congenic strain, NOD.B10-H2b, in which the NOD MHC I-Ag7Idd1 diabetes susceptibility locus was replaced by the MHC I-Ab locus [20], continued to show SjS-like disease, including salivary and lacrimal gland dysfunction. Second, replacing Idd loci other than Idd1 (for example, Idd9, Idd10, and Idd13) resulted in the identification of Idd3 on chromosome 3 and Idd5 on chromosome 1 as critical genetic regions for development of SjS-like disease in NOD mice [10]. In a reverse approach, introducing both Idd3 and Idd5 derived from NOD mice into SjS-nonsusceptible C57BL/6 mice resulted in a severe SjS-like disease, confirming the contributions of these two genetic loci to the development and onset of SjS [21]. Furthermore, the preclinical nonimmune aspects manifested in phase 1 of the disease appeared to associate with the Idd5 locus (referred to as autoimmune exocrinopathy 2 or Aec2), whereas the immunological aspects of the disease manifested in phases 2 and 3 of the disease appeared to associate with Idd3 (referred to as Aec1). This recently generated mouse strain is referred to as C57BL/6.NOD-Aec1Aec2. While the pathophysiological and immunological aspects may not be linked solely to one or the other genetic region (as originally proposed [22]), the complete disease profile requires genes within both of these genetic loci.
###end p 13
###begin p 14
###xml 94 96 94 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 131 133 131 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 531 536 531 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec1 </italic>
###xml 540 545 540 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec2 </italic>
###xml 584 593 584 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec1Aec2 </italic>
###xml 744 746 744 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 847 852 847 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec1 </italic>
###xml 950 962 950 962 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec1R01Aec2 </italic>
###xml 963 964 963 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1066 1070 1066 1070 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec2</italic>
###xml 1094 1107 1094 1107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec1Aec2R(n) </italic>
###xml 1149 1154 1149 1154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec2 </italic>
###xml 267 272 <span type="species:ncbi:9606">human</span>
###xml 593 597 <span type="species:ncbi:10090">mice</span>
For years, identification of candidate genes associated with autoimmune diseases such as T1D [23] or systemic lupus erythematosus [24] in animal models has been providing invaluable data on delineating the genetic components of these diseases, now translating to the human disease. These studies have formed a template for our current efforts to identify the SjS susceptibility loci and candidate genes underlying SjS which, in this respect, have lagged behind many other autoimmune diseases. Although our initial work defined the Aec1 and Aec2 genetic regions present in C57BL/6.NOD-Aec1Aec2 mice as being an approximately 48.5-cM centromeric region on chromosome 3 and an approximately 73.3-cM telomeric region on chromosome 1, respectively [10], the size of these regions precluded identification of candidate genes. Subsequently, we shortened Aec1 to an approximately 19.2-cM region in the first studied recombinant inbred (RI) line, C57BL/6.NOD-Aec1R01Aec2 [9]. For the present study, we generated a set of new RI lines that further demarcate the boundaries of Aec2. These new C57BL/6.NOD-Aec1Aec2R(n) RI lines identify not only a much shorter Aec2 sublocus at position 79 cM of chromosome 1, but also potential candidate SjS susceptibility genes on which to build hypothetical models that can be tested for validating possible pathogenic molecular mechanisms of SjS-like disease.
###end p 14
###begin title 15
Materials and methods
###end title 15
###begin title 16
Animals
###end title 16
###begin p 17
###xml 12 25 12 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec1Aec2R(n) </italic>
###xml 41 58 41 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec1R(n)Aec2R(n) </italic>
###xml 102 111 102 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec1Aec2 </italic>
###xml 279 284 279 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec1 </italic>
###xml 291 296 291 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec2 </italic>
###xml 391 396 391 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec2 </italic>
###xml 439 444 439 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec2 </italic>
###xml 58 62 <span type="species:ncbi:10090">mice</span>
###xml 111 115 <span type="species:ncbi:10090">mice</span>
###xml 130 134 <span type="species:ncbi:10090">mice</span>
###xml 360 364 <span type="species:ncbi:10090">mice</span>
###xml 422 427 <span type="species:ncbi:10090">mouse</span>
###xml 540 544 <span type="species:ncbi:10090">Mice</span>
C57BL/6.NOD-Aec1Aec2R(n) and C57BL/6.NOD-Aec1R(n)Aec2R(n) mice were generated by crossing C57BL/6.NOD-Aec1Aec2 mice with C57BL/6J mice purchased from The Jackson Laboratory (Bar Harbor, ME, USA). The F1 heterozygotes were screened for the presence of crossover events within the Aec1 and/or Aec2 genetic regions by microsatellite marker genotyping. Individual mice indicating a crossover in Aec2 were bred with a C57BL/6J mouse to produce Aec2 crossover heterozygous male and female offspring that were then used to produce F2 generations. Mice of the F2 generations were screened for a male and female homozygous for the crossover chromosome. Once an appropriate homozygous recombinant founder pair was identified, the RI line was maintained via a single line of descent.
###end p 17
###begin p 18
###xml 294 304 294 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ad libitum</italic>
###xml 484 485 484 485 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 199 203 <span type="species:ncbi:10090">mice</span>
###xml 265 269 <span type="species:ncbi:10090">mice</span>
###xml 345 349 <span type="species:ncbi:10090">mice</span>
All RI lines were bred and maintained under specific pathogen-free conditions in the animal facility of Animal Care Services of the University of Florida (Gainesville, FL, USA). Both male and female mice 4 to 24 weeks of age were used in the following studies. All mice received water and food ad libitum. Blood samples were collected while the mice were anesthetized with isoflurane. Euthanasia was carried out by cervical dislocation after anesthetization with isoflurane or 100% CO2. Studies described herein were approved by the University of Florida Institutional Animal Care and Use Committee.
###end p 18
###begin title 19
Genotyping
###end title 19
###begin p 20
###xml 324 329 324 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec2 </italic>
###xml 411 415 <span type="species:ncbi:10090">mice</span>
###xml 449 453 <span type="species:ncbi:10090">mice</span>
To determine the genetic status of each offspring, DNA was prepared using the DNeasy Tissue Kit (Qiagen Inc., Valencia, CA, USA) from a small tail snip taken between 2 and 4 weeks of age just prior to weaning. Each DNA sample was used as a template in polymerase chain reaction amplification with D1mit primers covering the Aec2 genetic region. Microsatellite markers that differentiated genes derived from NOD mice from those derived from C57BL/6J mice were chosen. Primer sequences for the microsatellite markers were based on sequences available from The Jackson Laboratory and purchased from Integrated DNA Technologies (IDT, Coralville, IA, USA).
###end p 20
###begin title 21
Measurement of saliva flow rates
###end title 21
###begin p 22
###xml 55 59 <span type="species:ncbi:10090">mice</span>
###xml 321 325 <span type="species:ncbi:10090">mice</span>
To measure stimulated flow rates of saliva, individual mice were weighed and given an intraperitoneal injection of 100 muL of a mixture containing isoproterenol (0.02 mg/1 mL of phosphate-buffered saline [PBS]) and pilocarpine (0.05 mg/1 mL of PBS). Saliva was collected for 10 minutes from the oral cavity of individual mice using a micropipette starting 1 minute after injection of the secretagogue. The volume of each saliva sample was measured. The saliva samples were then frozen at -80degreesC until analyzed.
###end p 22
###begin title 23
Histology
###end title 23
###begin p 24
###xml 28 41 28 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec1Aec2R(n) </italic>
###xml 41 45 <span type="species:ncbi:10090">mice</span>
###xml 172 177 <span type="species:ncbi:10090">mouse</span>
###xml 785 790 <span type="species:ncbi:10090">mouse</span>
Male and female C57BL/6.NOD-Aec1Aec2R(n) mice were euthanized at various ages as indicated in the text. Submandibular and lacrimal glands were surgically removed from each mouse and placed in 10% phosphate-buffered formalin for 24 hours. Fixed tissues were embedded in paraffin and sectioned at 5-mum thickness. Paraffin-embedded sections were de-paraffinized by immersing in xylene, followed by dehydrating in ethanol. The tissue sections were prepared and stained with hematoxylin and eosin dye (Histology Tech Services, Inc., Gainesville, FL, USA). Stained sections were observed at x 100 magnifications for glandular structure and leukocyte infiltration. To detect and determine leukocytic infiltrations in salivary and lacrimal glands, a single histological section per gland per mouse was examined by two individuals blinded to the RI lines. LF, defined as aggregates of greater than 50 leukocytes, were quantified for each section.
###end p 24
###begin title 25
Detection of anti-nuclear autoantibodies in the sera
###end title 25
###begin p 26
###xml 50 54 <span type="species:ncbi:10090">mice</span>
###xml 346 351 <span type="species:ncbi:10090">mouse</span>
###xml 544 548 <span type="species:ncbi:9925">goat</span>
###xml 554 559 <span type="species:ncbi:10090">mouse</span>
Anti-nuclear autoantibodies (ANAs) in the sera of mice were detected using an ANA screening kit (Immuno Concepts, Sacramento, CA, USA). Sera were tested at dilutions of 1:40, 1:80, and 1:160. Presented in this paper, however, are data from testing sera at 1:40 dilutions. In brief, HEp-2 fixed substrate slides were overlaid with the appropriate mouse serum. Slides were incubated for 30 minutes at room temperature in a humidified chamber. After three washes for 5 minutes with PBS, the substrate slides were covered with Alexa 594-conjugated goat anti-mouse IgG (H/L) (Invitrogen Corporation, Carlsbad, CA, USA) diluted 1:50 for 30 minutes at room temperature. After three washes, nuclear fluorescence was detected by fluorescence microscopy at x 100 magnification.
###end p 26
###begin title 27
Modeling of biological pathways using Pathway Studio
###end title 27
###begin p 28
###xml 78 83 78 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec2 </italic>
To model biological pathways from selected genes located within the redefined Aec2 genetic region, Pathway Studio version 5.0 software (Ariadne Genomics, Rockville, MD, USA) and the ResNet mammalian database were used. Functions of selected genes within the two genetic regions and known SjS-related genes were first verified from the ResNet mammalian database and then imported into Pathway Studio to visually construct molecular and biological interactions or relationships among the inputted genes.
###end p 28
###begin title 29
Statistical analyses
###end title 29
###begin p 30
###xml 679 681 679 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
###xml 784 786 784 786 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 113 117 <span type="species:ncbi:10090">mice</span>
###xml 193 197 <span type="species:ncbi:10090">mice</span>
###xml 393 397 <span type="species:ncbi:10090">mice</span>
###xml 475 479 <span type="species:ncbi:10090">mice</span>
###xml 553 557 <span type="species:ncbi:10090">mice</span>
For this study, we have standardized both saliva and tear collections based on the body weight of the individual mice in an attempt to better control comparisons. We have incorporated this for mice of the C57BL/6 genetic background because, first, disease tends to occur in the C57BL/6 genetic background strains at an earlier age, often necessitating collections of saliva and tears when the mice are as young as 4 to 6 weeks of age and are less than half the size of adult mice, and, second, there are greater size differences between male and female mice during the time course studied. Statistical evaluations between saliva collections were determined by using the unpaired t test generated by GraphPad InStat software (GraphPad Software, Inc., San Diego, CA, USA). A two-tailed P value of less than 0.05 was considered significant.
###end p 30
###begin title 31
Results
###end title 31
###begin title 32
Genetic profiling of the recombinant inbred lines
###end title 32
###begin p 33
###xml 58 67 58 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec1Aec2 </italic>
###xml 114 119 114 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec2 </italic>
###xml 186 191 186 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec2 </italic>
###xml 229 234 229 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec1 </italic>
###xml 238 242 238 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec2</italic>
###xml 336 341 336 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec2 </italic>
###xml 455 460 455 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec2 </italic>
###xml 505 510 505 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec2 </italic>
###xml 690 691 690 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 778 783 778 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec2 </italic>
###xml 288 292 <span type="species:ncbi:10090">mice</span>
###xml 800 804 <span type="species:ncbi:10090">mice</span>
From an initial mating of C57BL/6J males with C57BL/6.NOD-Aec1Aec2 females, we identified 49 unique crossovers in Aec2 of chromosome 1, consisting of 33 lines with a single crossover in Aec2 and 16 lines with a crossover in both Aec1 and Aec2. In addition, 2 lines were established using mice with pre-existing double-crossovers in the Aec2 region (RI lines 02 and 03). During the subsequent inbreeding, we were successful in generating 39 new homozygous Aec2 RI lines. To map each genetic segment of the Aec2 region remaining within each of the 39 newly generated RI lines, we selected microsatellite markers spaced approximately 4 to 5 cM apart along chromosome 1. As presented in Figure 1, these new RI lines, taken together, define progressively smaller genetic segments of Aec2 derived from NOD mice and permit much finer mapping for SjS susceptibility loci. Although there are at least two regions on chromosome 1 (around positions 50 and 75 cM) that exhibited higher numbers of recombinant events, there do not appear to be any crossover hotspots.
###end p 33
###begin p 34
###xml 52 65 52 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec1Aec2R(n) </italic>
###xml 185 190 185 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec2 </italic>
###xml 89 93 <span type="species:ncbi:10090">mice</span>
Map of chromosome 1 crossover points in C57BL/6.NOD-Aec1Aec2R(n) recombinant inbred (RI) mice. Thirty-nine RI lines are aligned to show the points of their individual crossovers in the Aec2 region of chromosome 1, as determined by D1mit microsatellite markers. Crossover frequencies are higher at approximately 49.7, 74.3, and 79.0 cM but are not considered hotspots for chromosomal 1 crossovers (NS: Not significant, * = p < 0.05, ** = p < 0.01, and *** = p < 0.001).
###end p 34
###begin title 35
Disease profiling of the recombinant inbred lines
###end title 35
###begin p 36
###xml 71 79 71 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec1Aec2</italic>
###xml 127 128 127 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 197 199 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 405 418 405 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec1Aec2R(n) </italic>
###xml 36 41 <span type="species:ncbi:10090">mouse</span>
###xml 189 195 <span type="species:ncbi:9606">humans</span>
###xml 418 422 <span type="species:ncbi:10090">mice</span>
###xml 538 542 <span type="species:ncbi:10090">mice</span>
###xml 631 635 <span type="species:ncbi:10090">mice</span>
SjS-like disease in our NOD-derived mouse lines, including C57BL/6.NOD-Aec1Aec2, is characterized generally by three criteria [4], reflecting the objective criteria used to identify SjS in humans [25]. These are (a) the loss of saliva and tear flow rates over time, (b) the presence of LF in the salivary and lacrimal glands, and (c) the presence of ANAs in sera. To determine which of the RI C57BL/6.NOD-Aec1Aec2R(n) mice develop salivary gland dysfunction, temporal changes in saliva flow rates were determined for both male and female mice at an early age (7 +/- 1 weeks) and then at a later age (22 +/- 2 weeks). The number of mice examined for each new RI line was dependent on the number of offspring produced in the first few pregnancies following inbreeding.
###end p 36
###begin p 37
###xml 160 169 160 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec1Aec2 </italic>
###xml 403 408 403 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec2 </italic>
###xml 437 438 437 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 548 553 548 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec1 </italic>
###xml 590 594 590 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec2</italic>
###xml 863 865 863 865 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H2</italic>
###xml 865 866 865 866 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 865 866 865 866 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>b</italic></sup>
###xml 884 893 884 893 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec1Aec2 </italic>
###xml 899 900 899 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 901 903 901 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 904 906 904 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 907 909 907 909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 910 912 910 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 169 173 <span type="species:ncbi:10090">mice</span>
###xml 474 478 <span type="species:ncbi:10090">mice</span>
###xml 721 725 <span type="species:ncbi:10090">mice</span>
###xml 893 897 <span type="species:ncbi:10090">mice</span>
###xml 947 951 <span type="species:ncbi:10090">mice</span>
###xml 1173 1177 <span type="species:ncbi:10090">mice</span>
Results indicate that the loss of secretory flow rates was clearly evident for several of the RI lines, thereby retaining the phenotype of parental C57BL/6.NOD-Aec1Aec2 mice, while a number of the RI lines also failed to show a loss of secretory activities, thereby indicating loss of the SjS-like disease phenotype. Selected yet representative data showing differences in salivary flow rates among the Aec2 RI lines are shown in Figure 2. For example, both male and female mice of RI lines RI09, RI33, and RI12, all of which retained the parental Aec1 region but carry various portions of Aec2, exhibited salivary gland dysfunction as measured by loss of salivary flow rates ranging generally between 35% and 60% as the mice aged from 8 to 20-24 weeks. These data are consistent with the decreases of saliva fluid volumes historically observed with NOD, NOD.B10-H2b, and C57BL/6.NOD-Aec1Aec2 mice [8,10,16,20,21]. In contrast, male and female RI mice of lines exhibiting little or no salivary gland dysfunction (for example, RI34 and RI02) generally showed slightly increased salivary flow rates over these same time frames, mimicking SjS-nonsusceptible parental C57BL/6J mice.
###end p 37
###begin p 38
###xml 74 87 74 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec1Aec2R(n) </italic>
###xml 146 155 146 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec1Aec2 </italic>
###xml 178 191 178 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec1Aec2R(n) </italic>
###xml 87 91 <span type="species:ncbi:10090">mice</span>
###xml 117 121 <span type="species:ncbi:10090">mice</span>
###xml 191 195 <span type="species:ncbi:10090">mice</span>
###xml 363 368 <span type="species:ncbi:10090">mouse</span>
###xml 525 530 <span type="species:ncbi:10090">mouse</span>
Differences in temporal loss of secretory function in various C57BL/6.NOD-Aec1Aec2R(n) mice. Male and female sibling mice of parental C57BL/6.NOD-Aec1Aec2 (P-DC) and C57BL/6.NOD-Aec1Aec2R(n) mice were injected with isoproterenol/pilocarpine, first at 8 weeks of age and then at 20 or 24 weeks of age, to stimulate saliva secretion. Saliva was collected from each mouse for 10 minutes starting 1 minute after injection of the secretagogue. The volume of each sample was measured and standardized relative to the weight of the mouse. Temporal reductions in saliva secretions, a marker for onset of clinical disease, were used to identify genetic regions containing genes necessary for development of salivary gland dysfunction and Sjogren syndrome. NS, not significant; RI, recombinant inbred.
###end p 38
###begin p 39
###xml 272 273 272 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 278 279 278 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 1104 1105 1104 1105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 74 82 <span type="species:ncbi:9606">patients</span>
###xml 163 171 <span type="species:ncbi:9606">patients</span>
###xml 188 192 <span type="species:ncbi:10090">mice</span>
###xml 628 632 <span type="species:ncbi:10090">mice</span>
Although the number of LF present in minor salivary gland biopsies of SjS patients often does not correlate directly with disease or severity of disease, both SjS patients and NOD-derived mice exhibiting SjS-like disease typically present with LF. As presented in Figures 3 and 4, histological examinations revealed the presence of LF in the submandibular and extraorbital lacrimal glands, starting at 8 to 12 weeks of age in all of the anticipated disease-susceptible RI strains (for example, RI06, RI09, RI33, and RI12). In contrast, no LF or at most only a relatively few, smaller LF were seen in the glands of RI34 and RI02 mice, correlating with their normal salivary flow rates. Interestingly, in addition to the lymphocytic infiltrates, increased levels of lipid deposits could be seen in the submandibular and lacrimal glands of several RI lines with onset of disease (data not shown). Quantification of LF in the salivary and lacrimal glands showing the relative differences in SjS-susceptible (RI06, RI09, RI12, and RI33) versus SjS-nonsusceptible (RI02 and RI34) RI lines is provided in Table 1.
###end p 39
###begin p 40
###xml 77 90 77 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec1Aec2R(n) </italic>
###xml 173 186 173 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec1Aec2R(n) </italic>
###xml 483 487 483 487 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 493 497 493 497 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 503 507 503 507 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c) </bold>
###xml 514 518 514 518 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(d) </bold>
###xml 524 528 524 528 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(e) </bold>
###xml 538 542 538 542 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(f) </bold>
###xml 90 94 <span type="species:ncbi:10090">mice</span>
###xml 186 190 <span type="species:ncbi:10090">mice</span>
Histological characterization of sialadenitis of male and female C57BL/6.NOD-Aec1Aec2R(n) mice. Submandibular glands were freshly explanted from male and female C57BL/6.NOD-Aec1Aec2R(n) mice euthanized at 20 or 24 weeks of age. The glands were fixed in 10% formalin, embedded in paraffin, and sectioned and stained with hematoxylin and eosin (H&E) dye. Representative H&E-stained histological sections of submandibular glands of selected recombinant inbred (RI) lines are presented: (a) RI34, (b) RI02, (c) RI06C, (d) RI09, (e) RI12, and (f) RI33. Original images were taken at x 100 magnification, with inserts expanded to show structural detail.
###end p 40
###begin p 41
###xml 79 92 79 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec1Aec2R(n) </italic>
###xml 188 201 188 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec1Aec2R(n) </italic>
###xml 493 497 493 497 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 503 507 503 507 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 513 517 513 517 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c) </bold>
###xml 524 528 524 528 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(d) </bold>
###xml 534 538 534 538 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(e) </bold>
###xml 548 552 548 552 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(f) </bold>
###xml 92 96 <span type="species:ncbi:10090">mice</span>
###xml 201 205 <span type="species:ncbi:10090">mice</span>
Histological characterization of dacryoadenitis of male and female C57BL/6.NOD-Aec1Aec2R(n) mice. Submandibular and lacrimal glands were freshly explanted from male and female C57BL/6.NOD-Aec1Aec2R(n) mice euthanized at 20 or 24 weeks of age. The glands were fixed in 10% formalin, embedded in paraffin, and sectioned and stained with hematoxylin and eosin (H&E) dye. Representative H&E-stained histological sections of lacrimal glands of selected recombinant inbred (RI) lines are presented: (a) RI34, (b) RI02, (c) RI06C, (d) RI09, (e) RI12, and (f) RI33. Original images were taken at x 100 magnification, with inserts expanded to show structural detail.
###end p 41
###begin p 42
###xml 119 132 119 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec1Aec2R(n) </italic>
###xml 74 78 <span type="species:ncbi:10090">mice</span>
Quantification of lymphocytic foci in the salivary and lacrimal glands of mice from several representative C57BL/6.NOD-Aec1Aec2R(n) recombinant inbred lines
###end p 42
###begin p 43
LF, lymphocytic foci; ND, not done; RI, recombinant inbred.
###end p 43
###begin p 44
###xml 272 281 272 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec1Aec2 </italic>
###xml 371 373 371 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 374 376 374 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 426 439 426 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec1Aec2R(n) </italic>
###xml 617 618 617 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 1282 1291 1282 1291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec1Aec2 </italic>
###xml 1314 1315 1314 1315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1405 1407 1405 1407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H2</italic>
###xml 1407 1409 1407 1409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b </italic>
###xml 1407 1409 1407 1409 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>b </italic></sup>
###xml 1729 1731 1729 1731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1864 1866 1864 1866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 81 86 <span type="species:ncbi:9606">human</span>
###xml 87 95 <span type="species:ncbi:9606">patients</span>
###xml 281 285 <span type="species:ncbi:10090">mice</span>
###xml 439 443 <span type="species:ncbi:10090">mice</span>
###xml 466 470 <span type="species:ncbi:10090">mice</span>
###xml 1162 1166 <span type="species:ncbi:10090">mice</span>
###xml 1291 1295 <span type="species:ncbi:10090">mice</span>
###xml 1308 1312 <span type="species:ncbi:10090">mice</span>
###xml 1373 1377 <span type="species:ncbi:10090">mice</span>
###xml 1409 1413 <span type="species:ncbi:10090">mice</span>
The presence of ANAs, in particular anti-SS-A/Ro and anti-SS-B/La in the sera of human patients, is one parameter in the diagnosis of clinical SjS. Concomitantly with the appearance of mononuclear leukocytes within the salivary and lacrimal glands of parental C57BL/6.NOD-Aec1Aec2 mice, increasing numbers and levels of detectable serum autoantibodies are also detected [26-29]. To identify ANAs in the sera of RI C57BL/6.NOD-Aec1Aec2R(n) mice, both male and female mice were serially bled between 6 and 24 weeks of age (until euthanasia) and the sera were collected and tested on HEp-2 cells. As presented in Figure 5, a number of different patterns of ANA staining, including speckled/homogenous nuclear, cytoplasmic/nuclear membrane, speckled cytoplasm, and cytoplasmic staining, were detected in the sera from different RI lines. Cytoplasmic with nuclear membrane and cytoplasmic staining patterns appeared to be more prevalent in sera from SjS-nonsusceptible RI lines (RI02 and RI34), whereas sera from SjS-susceptible RI lines such as RI06C, RI09, and RI46B produced predominantly speckled/homogenous staining patterns. In general, a majority of sera from mice classified as SjS-susceptible RI lines produced ANA staining patterns observed with sera from parental C57BL/6.NOD-Aec1Aec2 mice and not NOD mice [9]. This difference between the C57BL/6 background-derived mice versus the NOD and NOD.B10.H2b mice suggests that the ANA staining pattern is not disease-specific and that the genetic background plays an important role in which ANAs are synthesized. Furthermore, the speckled pattern of staining in these RI lines appears to be characteristic of the staining observed with anti-SS-A/Ro and anti-SS-B/La antibodies [30]. At the same time, the cytoplasmic punctate staining is characteristic of the staining observed with antibodies against GW bodies [31]. Confirmation of whether these antibodies are reactive with SS-A/Ro, SS-B/La, and/or GW bodies is currently ongoing.
###end p 44
###begin p 45
###xml 64 78 64 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec1RAec2R(n) </italic>
###xml 124 137 124 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec1Aec2R(n) </italic>
###xml 804 816 798 799 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#167;</sup>
###xml 78 82 <span type="species:ncbi:10090">mice</span>
###xml 137 141 <span type="species:ncbi:10090">mice</span>
###xml 319 323 <span type="species:ncbi:9925">goat</span>
###xml 329 334 <span type="species:ncbi:10090">mouse</span>
###xml 826 830 <span type="species:ncbi:10090">mice</span>
###xml 892 896 <span type="species:ncbi:10090">mice</span>
Detection of anti-nuclear autoantibodies in sera of C57BL/6.NOD-Aec1RAec2R(n) mice. Serum samples obtained from C57BL/6.NOD-Aec1Aec2R(n) mice were diluted 1:40 and incubated with HEp-2 fixed substrate slides for 30 minutes at 25degreesC in a humidified chamber. The slides were then developed with Alexa 594-conjugated goat anti-mouse IgG and viewed by fluorescence microscopy at x 100 magnification. Examples of speckled/homogenous staining of the nucleus (left panel), cytoplasmic/nuclear membrane staining (left center panel), speckled/cytoplasmic staining (right center panel), and cytoplasmic staining (right panel) were observed. The numbers of individual sera tested and the percentages of positive sera from a sampling of recombinant inbred (RI) lines exhibiting each of the patterns are listed. section signNumber of mice showing positive staining pattern over total. *Percentage of mice showing positive staining pattern. Aec, autoimmune exocrinopathy.
###end p 45
###begin title 46
###xml 47 52 47 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec2 </italic>
Redefining the Sjogren syndrome susceptibility Aec2 genetic region
###end title 46
###begin p 47
###xml 108 113 108 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec2 </italic>
###xml 262 263 262 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 483 488 481 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec1 </italic>
###xml 592 597 590 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec2 </italic>
###xml 237 241 <span type="species:ncbi:10090">mice</span>
###xml 663 668 <span type="species:ncbi:9606">human</span>
###xml 673 678 <span type="species:ncbi:10090">mouse</span>
###xml 736 740 <span type="species:ncbi:10090">mice</span>
Based on the disease profiling data, we are now able to tentatively identify a small segment (subregion) of Aec2 containing genes essential and sufficient for development and onset of SjS-like disease associated with NOD and NOD-derived mice. As shown in Figure 6, the primary (or candidate) SjS susceptibility gene(s) on chromosome 1 lay within a genetic region around 79 +/- 5 cM. SjS susceptibility genes within this sublocus must be coexpressed with the NOD-derived genes of the Aec1 region of chromosome 3 in order to induce a clinical disease. Not surprisingly, however, this redefined Aec2 subregion contains multiple genes already shown to correlate with human and mouse SjS as well as several additional autoimmune diseases in mice. These genes provide a basis for developing hypothetical models of molecular mechanisms underlying SjS, as discussed below.
###end p 47
###begin p 48
###xml 34 39 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec2 </italic>
###xml 142 155 142 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec1Aec2R(n) </italic>
###xml 208 213 208 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec2 </italic>
Redefining the boundaries for the Aec2 Sjogren Syndrome (SjS) susceptibility genetic locus. Based on the disease profiling of the C57BL/6.NOD-Aec1Aec2R(n) recombinant inbred (RI) lines, the boundaries of the Aec2 genetic region containing SjS susceptibility genes have been temporarily reset to position 79 +/- 5 cM of chromosome 1 (shaded gray gradient rectangular box). Possible quantitative trait loci genes may reside a few centimorgans centromeric to this region (unshaded rectangular box).
###end p 48
###begin title 49
Discussion
###end title 49
###begin p 50
###xml 100 105 100 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec2 </italic>
###xml 352 365 352 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec1Aec2R(n) </italic>
###xml 392 397 392 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec2 </italic>
###xml 427 436 427 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec1Aec2 </italic>
###xml 643 645 643 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1027 1032 1025 1030 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec2 </italic>
###xml 1386 1387 1384 1385 <sub xmlns:xlink="http://www.w3.org/1999/xlink">H</sub>
###xml 1555 1560 1553 1558 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec2 </italic>
###xml 1584 1589 1582 1587 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ath1 </italic>
###xml 1683 1690 1681 1688 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tnfsf4 </italic>
###xml 1693 1698 1691 1696 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ox40L</italic>
###xml 1704 1711 1702 1709 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tnfsf6 </italic>
###xml 1712 1716 1710 1714 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fasl</italic>
###xml 185 189 <span type="species:ncbi:10090">mice</span>
###xml 436 440 <span type="species:ncbi:10090">mice</span>
In the present study, in which the specific goal was to redefine (and narrow) the boundaries of the Aec2 genetic region on chromosome 1 known to predispose NOD and NOD-derived lines of mice to SjS, we generated a large set of new RI lines (n = 39) and examined each line for its SjS-like disease profile. Disease profiles obtained with the C57BL/6.NOD-Aec1Aec2R(n) RI lines indicate that the Aec2 genetic region of C57BL/6.NOD-Aec1Aec2 mice, postulated to regulate primarily the pathophysiological and biochemical abnormalities that subsequently result in the activation of the autoimmune attack against the submandibular and lacrimal glands [10], is a single subregion mapping to the telomeric portion of chromosome 1 located at approximately 79 +/- 5 cM. However, penetrance and severity of SjS-like disease may be further influenced by genes located within a few centimorgans on the centromeric side of this region, possibly pointing to SjS-associated quantitative trait loci (QTL) genes. Although the size of the redefined Aec2 region remains relatively large for identification of individual candidate SjS susceptibility genes, the genes residing within this subregion can be grouped into four functionally clustered sets, each suspected previously of involvement in SjS susceptibility. These are (a) endogenous viruses and oncogenic genes, (b) Fas/FasL-associated apoptosis, (c) TH17-associated activities, and (d) fatty acid, lipid, lipoprotein, and cholesterol homeostasis. However, perhaps the most obvious aspect is the fact that this redefined Aec2 region contains the QTL-Ath1 region containing some 10 genes, including tumor necrosis factor ligand superfamily member 4 (Tnfsf4 or Ox40L) and Tnfsf6 (Fasl).
###end p 50
###begin p 51
###xml 61 67 61 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Emv38 </italic>
###xml 99 110 99 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kras-2-rs1 </italic>
###xml 164 169 164 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xpr1 </italic>
###xml 220 225 220 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Abl2 </italic>
###xml 297 302 297 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec2 </italic>
###xml 351 353 351 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1016 1023 1004 1011 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tnfsf6 </italic>
###xml 1192 1193 1180 1181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 1455 1457 1443 1445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 119 122 <span type="species:ncbi:10116">rat</span>
###xml 234 240 <span type="species:ncbi:10090">murine</span>
###xml 345 349 <span type="species:ncbi:10090">mice</span>
###xml 464 468 <span type="species:ncbi:10090">mice</span>
###xml 618 622 <span type="species:ncbi:10090">mice</span>
###xml 1255 1259 <span type="species:ncbi:10090">mice</span>
Within the first set, several viral/oncogenic genes, such as Emv38 (endogenous ecotropic MuLV-38), Kras-2-rs1 (Kirsten rat sarcoma oncogene-2, related sequence-1), Xpr1 (xenotropic/polytropic retrovirus receptor-1), and Abl2 (Abelson murine leukemia viral oncogene-2), are found in this redefined Aec2 subregion. In our earlier studies with NOD mice [12], we observed that high levels of interferon-gamma (INF-gamma) were present in the salivary glands of neonate mice, suggesting an important role for INF-gamma in the delayed development/proliferation of acinar tissue observed in the salivary glands of neonate NOD mice. While it is logical to conclude that induction of INF-gamma may be a result of short-term viral infection during the preterm and early postpartum periods, what might cause a viral outbreak at this time point remains unknown. It could be hypothesized that this occurs due to the changes in maternal hormone levels at this time. Perhaps more interesting, however, this region contains the gene Tnfsf6 encoding the proapoptotic protein FasL. FasL has numerous functions but is mainly involved in regulating immune responses, apoptosis, and retinal cell programmed death [4]. During the early phase 1 period of SjS-like disease in NOD mice, both FasL and Fas are upregulated at both the gene and protein levels, and this increased expression of Fas/FasL corresponds to the observed increase in acinar cell apoptosis within the glands [32]. However, it remains speculative whether there might be an association between endogenous/exogenous viral infection and Fas/FasL activity in the salivary and lacrimal glands.
###end p 51
###begin p 52
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec2 </italic>
###xml 373 377 373 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pdc </italic>
###xml 446 448 446 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 455 460 455 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myoc </italic>
###xml 536 538 536 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 861 867 861 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cypr2 </italic>
###xml 892 894 892 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 1077 1078 1077 1078 <sub xmlns:xlink="http://www.w3.org/1999/xlink">H</sub>
###xml 1085 1086 1085 1086 <sub xmlns:xlink="http://www.w3.org/1999/xlink">H</sub>
###xml 1096 1098 1096 1098 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 1145 1150 1145 1150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Il10 </italic>
###xml 1218 1227 1218 1227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec1Aec2 </italic>
###xml 1240 1242 1240 1242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1311 1314 1311 1314 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg</sub>
###xml 1596 1598 1596 1598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 1599 1601 1599 1601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 187 195 <span type="species:ncbi:9606">patients</span>
###xml 1227 1232 <span type="species:ncbi:10090">mouse</span>
###xml 1590 1594 <span type="species:ncbi:10090">mice</span>
The redefined Aec2 subregion also contains several genes involved in autoimmunity and/or tumorgenesis, the latter being one clinical manifestation of SjS that occurs in a small subset of patients. Of interest, but not thought to be directly involved in the development and onset of SjS, is the presence of genes specific to the ocular/lacrimal gland etiology (for example, Pdc [phosducin], which is a protein of the retinal photoreceptors cells [33], and Myoc [myocilin], whose product interacts with olfactemedin involved in glaucoma [34]). However, whether any of these genes are related to SjS susceptibility and lacrimal gland disease or merely influence the secondary disease phenotypes often associated with SjS remains unknown. In contrast, one genetic element in this region that has a direct association with the immunopathology of SjS is the QTL gene Cypr2 (cytokine production 2) [35]. CYPR-2 is known to regulate levels of interleukin-10 (IL-10), an important cytokine that enhances the activity of B lymphocytes, and at the same time to regulate the functions of TH1 and TH17 cells [36]. Our recent microarray studies indicate that Il10 is not upregulated during the development of SjS in the C57BL/6.NOD-Aec1Aec2 mouse model [32], possibly indicating a lack of immune regulation by regulatory T (Treg) cells. If so, this lack of regulation by IL-10 would be consistent with the results of gene therapy studies in which injections of vectors expressing recombinant IL-10 reduced or suppressed clinical manifestations of SjS-like disease in both salivary and lacrimal glands of mice [37,38].
###end p 52
###begin p 53
###xml 160 161 160 161 <sub xmlns:xlink="http://www.w3.org/1999/xlink">H</sub>
###xml 165 166 165 166 <sub xmlns:xlink="http://www.w3.org/1999/xlink">H</sub>
###xml 170 171 170 171 <sub xmlns:xlink="http://www.w3.org/1999/xlink">H</sub>
###xml 180 184 180 184 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 285 292 285 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tnfsf4 </italic>
###xml 343 348 343 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec2 </italic>
###xml 454 456 454 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 529 532 529 532 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg</sub>
###xml 541 543 541 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 677 679 673 675 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 680 681 676 677 <sub xmlns:xlink="http://www.w3.org/1999/xlink">H</sub>
###xml 691 693 687 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 705 708 701 704 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg</sub>
###xml 812 814 808 810 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 815 816 811 812 <sub xmlns:xlink="http://www.w3.org/1999/xlink">H</sub>
###xml 833 834 829 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 853 854 849 850 <sub xmlns:xlink="http://www.w3.org/1999/xlink">H</sub>
###xml 986 987 982 983 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1114 1116 1110 1112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 1162 1163 1158 1159 <sub xmlns:xlink="http://www.w3.org/1999/xlink">H</sub>
###xml 1223 1232 1219 1228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec1Aec2 </italic>
###xml 1263 1265 1259 1261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 1299 1300 1295 1296 <sub xmlns:xlink="http://www.w3.org/1999/xlink">H</sub>
###xml 1304 1307 1300 1303 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg</sub>
###xml 1329 1330 1325 1326 <sub xmlns:xlink="http://www.w3.org/1999/xlink">H</sub>
###xml 1442 1444 1438 1440 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1445 1449 1441 1445 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 1508 1509 1504 1505 <sub xmlns:xlink="http://www.w3.org/1999/xlink">H</sub>
###xml 1519 1521 1515 1517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 1596 1600 1592 1596 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rxr </italic>
###xml 1626 1630 1622 1626 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rar </italic>
###xml 1711 1720 1707 1716 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec1Aec2 </italic>
###xml 1726 1728 1722 1724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 1907 1909 1903 1905 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1910 1914 1906 1910 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 2063 2064 2059 2060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 2114 2116 2110 2112 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 2117 2118 2113 2114 <sub xmlns:xlink="http://www.w3.org/1999/xlink">H</sub>
###xml 2130 2132 2126 2128 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 2133 2137 2129 2133 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 2359 2363 2355 2359 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 2493 2494 2489 2490 <sub xmlns:xlink="http://www.w3.org/1999/xlink">H</sub>
###xml 1232 1236 <span type="species:ncbi:10090">mice</span>
###xml 1253 1261 <span type="species:ncbi:9606">patients</span>
###xml 1720 1724 <span type="species:ncbi:10090">mice</span>
Maintaining sufficient regulation of immune responses to prevent development of an overt autoimmunity is no doubt dependent on a physiological balance between TH1, TH2, TH17, and Treg cell interactions. This cellular interaction appears to be highly influenced by OX40L encoded by the Tnfsf4 gene and this gene is located within the redefined Aec2 region. OX40L is expressed by a number of distinct cell populations, including activated dendritic cells [39]. OX40L is capable of functioning as an inhibitor of the maturation of Treg1 cells [40], a regulatory cell population normally producing IL-10 and INF-gamma, which (in conjunction with IL-27) can inhibit the effector CD4+ TH17 cells [41]. Reduced Treg1 cell function, therefore, results in a positive feedback for the generation/activation of effector CD4+ TH17 cells (Figure 7). These effector TH17 cells produce predominantly IL-17, IL-21, and IL-22 plus factors like nitric oxide, matrix metalloproteinase, and prostaglandin E2, each of which is shown to play an important role in the immunopathophysiology of several autoimmune diseases, including SjS [41]. Thus, we hypothesize that the presence of TH17 cells in the salivary and lacrimal glands of C57BL/6.NOD-Aec1Aec2 mice, as well as SjS patients [42], indicates an imbalance in the TH17/Treg1 ratio favoring the TH17 population(s). A recent study indicates that retinoic acid can facilitate an increase in the numbers of Foxp3+ Treg cells and simultenously inhibit the formation of effector TH17 cells [43]. Interestingly, we have found that expression of the retinoic receptors, Rxr (retinoid x receptor) and Rar (retinoic acid receptor), is downregulated in the lacrimal glands of C57BL/6.NOD-Aec1Aec2 mice [44]. This observation is again consistent with a potential problem in cellular homeostasis, especially at the level of macrophages, dendritic cells, and even production of the FOXP3+ Treg cell populations whose differentiation and functional maturation are highly dependent on retinoic and fatty acid stimulation. As presented in Figure 7, there is a reciprocal maturation of effector CD4+ TH17 and FOXP3+ Treg cells dependent on the relative balance of IL-6 and transforming growth factor-beta influenced by retinoic acid. Thus, the intricacy and balance between OX40L, the retinoids, proinflammatory cytokines, and development of Treg cells appear to impact the potential development and onset of autoimmunity, which in SjS appears to favor activation of effector TH17 cells.
###end p 53
###begin p 54
###xml 104 113 104 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec1Aec2 </italic>
###xml 402 403 398 399 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 420 421 416 417 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 467 470 460 463 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg</sub>
###xml 113 117 <span type="species:ncbi:10090">mice</span>
Proposed model for how OX40L:OX40 promotes autoimmunity in Sjogren syndrome-like disease of C57BL/6.NOD-Aec1Aec2 mice. Cellular interactions involved in the development of an autoimmune response against the salivary and lacrimal glands leading to loss of acinar tissue are presented. DC, dendritic cell; IL, interleukin; INF-gamma, interferon-gamma; MMP, matrix metalloproteinase; NO, nitric oxide, PGE2, prostaglandin E2; TGF-beta, transforming growth factor-beta; Treg, regulatory T (cell).
###end p 54
###begin p 55
###xml 59 64 59 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec2 </italic>
###xml 368 377 368 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec1Aec2 </italic>
###xml 548 555 548 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hdlq14 </italic>
###xml 590 596 590 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hdlq5 </italic>
###xml 599 605 599 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apoa2 </italic>
###xml 639 645 639 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpa33 </italic>
###xml 665 669 665 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cq1 </italic>
###xml 690 696 690 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prdx6 </italic>
###xml 735 741 735 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Soat1 </italic>
###xml 896 898 896 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 928 930 928 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 1058 1060 1058 1060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 1061 1063 1061 1063 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 1412 1413 1412 1413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8</xref>
###xml 2713 2715 2709 2711 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
Although several factors encoded by genes in the redefined Aec2 region may be involved in secondary manifestations of SjS, OX40L is the one factor that clearly stands out as a primary candidate gene underlying not only the recognized immune dysregulation, as presented above, but also the pathophysiological aberrations associated with chromosome 1 of the C57BL/6.NOD-Aec1Aec2 SjS model. In this redefined region, a common functional cluster of lipid, lipoprotein, cholesterol, and fatty acid regulatory and processing elements is found, including Hdlq14 (high-density lipoprotein QLT-14), Hdlq5 or Apoa2 (high-density lipoprotein QTL-5), Gpa33 (glycoprotein A33), Cq1 (cholesterol QTL-1), Prdx6 (peroxiredoxin), and (of special note) Soat1 (sterol O-acyltransferase-1). Involvement of lipids and fatty acids in the pathology of SjS has become a major focus of SjS research as lipid depositions [45] and changes in lipid rafts [46] appear to influence the pathology in both salivary and lacrimal glands. Furthermore, our recent genomic microarray studies - [44,47] (C.Q. Nguyen, S. Ashok, R.A McIndoe, J.X. She, B.H. Lee, A.B. Peck, unpublished data) - indicate that multiple genes involved in fatty acid, lipid, lipoprotein, and cholesterol homeostasis/transport are differentially expressed, corresponding with lipid deposits, dysfunctional dendritic cells, and onset of autoimmunity. As illustrated in Figure 8, various relationships between genes controlling free fatty acid, lipid, and lipoprotein homeostasis are directly or indirectly dependent on the activities of OX40L. As a consequence, imbalances in this homeostasis regulated in part by OX40/OX40L can result in widespread pathology, including inflammation and cell death. Based on differential gene expression data, there are major reductions in the levels of transcripts encoding FDFT-1 (farnesyl diphosphate farnesyl transferase-1), ABCA1 (ATP-binding cassette, subfamily A [ABC1] member 1), and the retinoic acid receptors, RRX and RAR. At the same time, increased levels of transcripts encoding the low- and high-density lipoprotein receptors, as well as SOAT-1, are observed. We hypothesize, therefore, that an imbalance occurs in the production of cholesterol and the increased level of cholesterol results in greater amounts being converted by SOAT-1 to cholesteryl esters that accumulate within the cells due to the downregulation or dysfunction of the lipid transporter. In addition, the functional activities of cells whose differentiation and maturation are dependent on the retinoids and the RXR/RAR-PPARgamma (RXR/RAR-peroxisome proliferator activated receptor-gamma) signaling pathways (for example, macrophages and dendritic and FOXP3+ T cells) will be altered due to altered development, ultimately affecting antigen presentation and balanced production of regulatory cytokines.
###end p 55
###begin p 56
###xml 213 222 213 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec1Aec2 </italic>
###xml 1132 1134 1132 1134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 222 226 <span type="species:ncbi:10090">mice</span>
###xml 248 256 <span type="species:ncbi:9606">patients</span>
Proposed genetic predisposition for dysregulated homeostasis/transport of lipid, lipoprotein, cholesterol, and fatty acid metabolism leading to lipid depositions in the salivary and lacrimal glands of C57BL/6.NOD-Aec1Aec2 mice and Sjogren syndrome patients. Accumulation of free cholesterols (FCs) inside the cells resulted from increased uptake of low- and high-density lipid receptors. In addition, impairment of ABCA1 membrane transporter leads to the accumulation of cholesteryl esters (CEs) metabolized by sterol O-acyltransferase-1 (SOAT-1) using FCs and free fatty acids (FFAs). ABCA1, ATP-binding cassette, subfamily A [ABC1] member 1; ACAT, acyl-coenzyme A: cholesterol acyltransferase; ApoE, apolipoprotein E; DC, dendritic cell; Fdft-1, farnesyl diphosphate farnesyl transferase-1; HDL, high-density lipid; LDL, low-density lipid; Lrpr, low-density lipid-related protein receptor; NCEH, neutral cholesterol esters hydrolase; Ox-LDL, oxidized low-density lipid; PPAR, peroxisome proliferator activated receptor; RANTES, regulated on activation normal T cell expressed and secreted; RXR, retinoid x receptor. Adapted from [48].
###end p 56
###begin title 57
Conclusion
###end title 57
###begin p 58
###xml 67 72 67 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aec2 </italic>
###xml 299 305 299 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ox40L </italic>
###xml 510 516 510 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ox40L </italic>
###xml 407 411 <span type="species:ncbi:10090">mice</span>
###xml 576 581 <span type="species:ncbi:9606">human</span>
Identifying gene products that are differentially expressed in the Aec2 SjS susceptibility subregion defined by the new RI lines is moving us closer to identifying specific candidate genes involved in the onset and development of SjS-like disease. Based on our current data, our focus is turning to Ox40L as an effective candidate gene for the development of SjS. The future application of genetic knockout mice and/or short interfering RNA will permit us to further our understanding of the potential role of Ox40L in SjS and, more importantly, to translate its relevancy to human SjS.
###end p 58
###begin title 59
Abbreviations
###end title 59
###begin p 60
###xml 454 457 450 453 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg</sub>
Aec: autoimmune exocrinopathy; ANA: anti-nuclear autoantibody; IL: interleukin; INF-gamma: interferon-gamma; LF: lymphocytic foci; MHC: major histocompatibility complex; NOD: nonobese diabetic; PBS: phosphate-buffered saline; QTL: quantitative trait loci; RAR: retinoic acid receptor; RI: recombinant inbred; RXR: retinoid x receptor; SjS: Sjogren syndrome; SOAT-1: sterol O-acyltransferase-1; TNFSF4: tumor necrosis factor ligand superfamily member 4; Treg: T regulatory.
###end p 60
###begin title 61
Competing interests
###end title 61
###begin p 62
The authors declare that they have no competing interests.
###end p 62
###begin title 63
Authors' contributions
###end title 63
###begin p 64
###xml 32 36 <span type="species:ncbi:10090">mice</span>
###xml 213 217 <span type="species:ncbi:10090">mice</span>
ABP performed the genotyping of mice and assisted with the study design and manuscript preparation. JT carried out histological analysis. JGC, LC, and JN performed saliva collections and disease profilings of the mice. BHL helped with manuscript preparation. CQN participated in the design of the study, ANA staining, saliva collections, data analyses, and manuscript preparation. All authors read and approved the final manuscript.
###end p 64
###begin title 65
Acknowledgements
###end title 65
###begin p 66
We thank Robert Haynes for the countless hours spent in caring for and maintaining precise records of these RI lines and Sung Kim for his help in analyzing the function and pathway associations of selected genes. This work was supported in part by Public Health Service (PHS) grant DE014344 from the National Institutes of Health (to ABP) and by the Center for Orphaned Autoimmune Disorders at the University of Florida. CQN was supported by a postdoctoral fellowship from PHS grant T32 DE07200.
###end p 66
###begin article-title 67
Pathogenesis of Sjogren's syndrome
###end article-title 67
###begin article-title 68
New concepts in the pathogenesis of Sjogren syndrome: many questions, fewer answers
###end article-title 68
###begin article-title 69
Current concepts on diagnosis, autoantibodies and therapy in Sjogren's syndrome
###end article-title 69
###begin article-title 70
###xml 41 45 <span type="species:ncbi:10090">mice</span>
Sjogren's syndrome (SjS)-like disease of mice: the importance of B lymphocytes and autoantibodies
###end article-title 70
###begin article-title 71
###xml 44 48 <span type="species:ncbi:10090">mice</span>
Breeding of a non-obese, diabetic strain of mice
###end article-title 71
###begin article-title 72
###xml 67 72 <span type="species:ncbi:10090">mouse</span>
Abnormal distribution of aquaporin-5 in salivary glands in the NOD mouse model for Sjogren's syndrome
###end article-title 72
###begin article-title 73
###xml 99 104 <span type="species:ncbi:10090">mouse</span>
Defective signalling in salivary glands precedes the autoimmune response in the non-obese diabetic mouse model of sialadenitis
###end article-title 73
###begin article-title 74
###xml 44 49 <span type="species:ncbi:10090">mouse</span>
Utilization of the non-obese diabetic (NOD) mouse as an animal model for the study of secondary Sjogren's syndrome
###end article-title 74
###begin article-title 75
###xml 57 61 <span type="species:ncbi:10090">mice</span>
Sjogren's syndrome-like disease of C57BL/6.NOD-Aec1 Aec2 mice: gender differences in keratoconjunctivitis sicca defined by a cross-over in the chromosome 3 Aec1 locus
###end article-title 75
###begin article-title 76
###xml 40 44 <span type="species:ncbi:10090">mice</span>
Alleles from chromosomes 1 and 3 of NOD mice combine to influence Sjogren's syndrome-like autoimmune exocrinopathy
###end article-title 76
###begin article-title 77
###xml 99 104 <span type="species:ncbi:10090">mouse</span>
IL-4-dependent effector phase in autoimmune exocrinopathy as defined by the NOD.IL-4-gene knockout mouse model of Sjogren's syndrome
###end article-title 77
###begin article-title 78
###xml 130 135 <span type="species:ncbi:10090">mouse</span>
A dual role for interferon-gamma in the pathogenesis of Sjogren's syndrome-like autoimmune exocrinopathy in the nonobese diabetic mouse
###end article-title 78
###begin article-title 79
###xml 80 85 <span type="species:ncbi:10090">mouse</span>
Progress in understanding autoimmune exocrinopathy using the non-obese diabetic mouse: an update
###end article-title 79
###begin article-title 80
Abnormal organogenesis in salivary gland development may initiate adult onset of autoimmune exocrinopathy
###end article-title 80
###begin article-title 81
###xml 108 116 <span type="species:ncbi:9606">patients</span>
Detection of anti-type 3 muscarinic acetylcholine receptor autoantibodies in the sera of Sjogren's syndrome patients by use of a transfected cell line assay
###end article-title 81
###begin article-title 82
###xml 30 35 <span type="species:ncbi:10090">mouse</span>
Sjogren's syndrome in the NOD mouse model is an interleukin-4 time-dependent, antibody isotype-specific autoimmune disease
###end article-title 82
###begin article-title 83
###xml 12 17 <span type="species:ncbi:9606">human</span>
###xml 59 63 <span type="species:ncbi:10090">mice</span>
Transfer of human serum IgG to nonobese diabetic Igmu null mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sjogren's syndrome
###end article-title 83
###begin article-title 84
###xml 114 118 <span type="species:ncbi:10090">mice</span>
Infiltrating lymphocyte populations and cytokine production in the salivary and lacrimal glands of autoimmune NOD mice
###end article-title 84
###begin article-title 85
###xml 103 108 <span type="species:ncbi:10090">mouse</span>
###xml 209 213 <span type="species:ncbi:10090">mice</span>
Genetically programmed development of salivary gland abnormalities in the NOD (nonobese diabetic)-scid mouse in the absence of detectable lymphocytic infiltration: a potential trigger for sialoadenitis of NOD mice
###end article-title 85
###begin article-title 86
###xml 20 26 <span type="species:ncbi:10090">murine</span>
A novel NOD-derived murine model of primary Sjogren's syndrome
###end article-title 86
###begin article-title 87
###xml 141 147 <span type="species:ncbi:10090">murine</span>
Two NOD Idd-associated intervals contribute synergistically to the development of autoimmune exocrinopathy (Sjogren's syndrome) on a healthy murine background
###end article-title 87
###begin article-title 88
Sjogren's syndrome: immunological response underlying the disease
###end article-title 88
###begin article-title 89
###xml 82 86 <span type="species:ncbi:10090">mice</span>
Three recessive loci required for insulin-dependent diabetes in nonobese diabetic mice
###end article-title 89
###begin article-title 90
###xml 39 45 <span type="species:ncbi:10090">murine</span>
Polygenic control of susceptibility to murine systemic lupus erythematosus
###end article-title 90
###begin article-title 91
Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group
###end article-title 91
###begin article-title 92
###xml 58 66 <span type="species:ncbi:9606">patients</span>
Ro/SSA and La/SSB specific IgA autoantibodies in serum of patients with Sjogren's syndrome and systemic lupus erythematosus
###end article-title 92
###begin article-title 93
Predominance of IgG1 subclass of anti-Ro/SSA, but not anti-La/SSB antibodies in primary Sjogren's syndrome
###end article-title 93
###begin article-title 94
Antibodies to carbonic anhydrase and IgG4 levels in idiopathic chronic pancreatitis: relevance for diagnosis of autoimmune pancreatitis
###end article-title 94
###begin article-title 95
###xml 37 45 <span type="species:ncbi:9606">patients</span>
Anti-Ro (SS-A) and anti-La (SS-B) in patients with Sjogren's syndrome
###end article-title 95
###begin article-title 96
###xml 96 101 <span type="species:ncbi:9606">human</span>
Routine immunofluorescence detection of Ro/SS-A autoantibody using HEp-2 cells transfected with human 60 kDa Ro/SS-A
###end article-title 96
###begin article-title 97
Autoantibodies to protein transport and messenger RNA processing pathways: endosomes, lysosomes, Golgi complex, proteasomes, assemblyosomes, exosomes, and GW bodies
###end article-title 97
###begin article-title 98
###xml 94 98 <span type="species:ncbi:10090">mice</span>
Inappropriate apoptosis of salivary and lacrimal gland epithelium of immunodeficient NOD-scid mice
###end article-title 98
###begin article-title 99
The pharmacology of phosducin
###end article-title 99
###begin article-title 100
Functional analysis of the glaucoma-causing TIGR/myocilin protein: integrity of amino-terminal coiled-coil regions and olfactomedin homology domain is essential for extracellular adhesion and secretion
###end article-title 100
###begin article-title 101
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vivo </italic>
In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjogren's syndrome, and systemic lupus erythematosus. A potential mechanism of B lymphocyte hyperactivity and autoimmunity
###end article-title 101
###begin article-title 102
###xml 65 67 65 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
IL-15 exacerbates collagen-induced arthritis with an enhanced CD4+ T cell response to produce IL-17
###end article-title 102
###begin article-title 103
###xml 6 28 <span type="species:ncbi:272636">adeno-associated virus</span>
###xml 102 108 <span type="species:ncbi:10090">murine</span>
Local adeno-associated virus-mediated interleukin 10 gene transfer has disease-modifying effects in a murine model of Sjogren's syndrome
###end article-title 103
###begin article-title 104
Prophylactic effect of IL-10 gene transfer on induced autoimmune dacryoadenitis
###end article-title 104
###begin article-title 105
###xml 30 36 <span type="species:ncbi:10090">murine</span>
###xml 41 46 <span type="species:ncbi:9606">human</span>
###xml 93 98 <span type="species:ncbi:9606">human</span>
Molecular characterization of murine and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV-1-regulated protein gp34
###end article-title 105
###begin article-title 106
OX40 ligand shuts down IL-10-producing regulatory T cells
###end article-title 106
###begin article-title 107
Induction and effector functions of T(H)17 cells
###end article-title 107
###begin article-title 108
###xml 105 111 <span type="species:ncbi:9606">humans</span>
###xml 116 120 <span type="species:ncbi:10090">mice</span>
Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjogren's syndrome: findings in humans and mice
###end article-title 108
###begin article-title 109
###xml 29 31 29 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression
###end article-title 109
###begin article-title 110
###xml 180 185 <span type="species:ncbi:10090">mouse</span>
Differential gene expressions in the lacrimal gland during development and onset of keratoconjunctivitis sicca in Sjogren's syndrome (SjS)-like disease of the C57BL/6.NOD-Aec1Aec2 mouse
###end article-title 110
###begin article-title 111
Serum lipid levels in Sjogren's syndrome
###end article-title 111
###begin article-title 112
###xml 44 47 <span type="species:ncbi:10116">rat</span>
Aquaporin-5 water channel in lipid rafts of rat parotid glands
###end article-title 112
###begin article-title 113
###xml 89 94 <span type="species:ncbi:10090">mouse</span>
Early pathogenic events associated with Sjogren's syndrome (SjS)-like disease of the nod mouse using microarray analysis
###end article-title 113
###begin article-title 114
The macrophage foam cell as a target for therapeutic intervention
###end article-title 114

